Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0597f9c318d2aeca86db94711c516383 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1793 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-177 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-525 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
filingDate |
2001-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd7600d888ab71c4732c3d28a0d746c6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4167ee7fc5229e7e31b46e306bfe4046 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdc94b6c07e91140cd514ef41de08983 |
publicationDate |
2002-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2002119924-A1 |
titleOfInvention |
Combination therapy using a TNF binding protein for treating TNF-mediated diseases |
abstract |
The invention relates to methods for treating or preventing acute and/or chronic arthritis. The method comprises administering to patients in need thereof therapeutically effective amounts of a TNF binding protein and methotrexate (N-[4-[[2,4-diamino-6-pteridinyl)methylamino]benzoyl]-L-glutamic acid). In a preferred embodiment, the TNF binding protein is sTNFR-I or sTNFR-II. The invention also relates to pharmaceutical compositions containing a TNF binding protein and methotrexate useful in such methods. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003204066-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003180299-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003133935-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7135179-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7128908-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8541182-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7223396-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008051365-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016280776-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003194402-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006018905-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006018906-A1 |
priorityDate |
1996-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |